<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <constitutionalAuthorityStatementText><![CDATA[<pre>By Mr. RAHALL:H.R. 672.Congress has the power to enact this legislation pursuantto the following:Clause 3 of Section 8 of Article I of Constitution[Page H503]</pre>]]></constitutionalAuthorityStatementText>
    <latestAction>
      <links />
      <actionDate>2013-04-08</actionDate>
      <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations.</text>
    </latestAction>
    <congress>113</congress>
    <summaries>
      <billSummaries>
        <item>
          <updateDate>2013-02-13T05:00:00Z</updateDate>
          <text><![CDATA[<p> Prescription Drug Abuse Prevention and Treatment Act of 2013 - Amends the Public Health Service Act to direct the Administrator of the Substance Abuse and Mental Health Services Administration to award grants to states and nonprofit entities for consumer education about opioid abuse, including methadone abuse.</p> <p>Amends the Controlled Substances Act to: (1) set forth training requirements for practitioners registered to prescribe or dispense methadone or other opioids, and (2) require each registered opioid treatment clinic to make acceptable arrangements for each patient who is restricted from having a take-home dose of a controlled substance related to treatment to receive a dose of that substance under appropriate supervision when the clinic is closed.</p> <p>Prohibits any individual or entity (except hospitals that provide direct patient supervision) from prescribing or dispensing a 40-mg diskette of methadone unless such prescription or dispensation is consistent with the current Drug Enforcement Administration (DEA) methadone policy, until the date the Controlled Substances Clinical Standards Commission: (1) publishes dosing guidelines for methadone, and (2) finds that such 40-mg diskettes are safe and clinically appropriate. Requires the Secretary of Health and Human Services (HHS) to establish such Commission to develop and publish guidelines related to methadone use, including safe dosing guidelines for all forms of methadone and benchmark guidelines for the reduction of methadone abuse.</p> <p>Requires states receiving controlled substances monitoring program grants to: (1) provide information, upon request, to drug enforcement officials relating to an individual who is the subject of an active drug-related investigation; and (2) require opioid-related deaths to be reported to the Administrator. </p> <p>Directs the Administrator to develop a Model Opioid Treatment Program Mortality Report.</p> <p>Requires the Administrator to establish and implement, through the National Center for Health Statistics, a National Opioid Death Registry to track opioid-related deaths.</p> <p>Requires the Secretary, acting through the Director of the Agency for Healthcare Research and Quality (AHRQ), to require the development and application of specific prescription drug abuse prevention and treatment quality measures for each relevant health care provider setting.</p>]]></text>
          <actionDate>2013-02-13</actionDate>
          <actionDesc>Introduced in House</actionDesc>
          <name>Introduced in House</name>
          <lastSummaryUpdateDate>2013-03-08T20:43:56Z</lastSummaryUpdateDate>
          <versionCode>00</versionCode>
        </item>
      </billSummaries>
    </summaries>
    <cboCostEstimates />
    <calendarNumbers />
    <billType>HR</billType>
    <committees>
      <billCommittees>
        <item>
          <activities>
            <item>
              <date>2013-02-13T15:08:35Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <chamber>House</chamber>
          <type>Standing</type>
          <subcommittees>
            <item>
              <activities>
                <item>
                  <date>2013-04-08T21:12:44Z</date>
                  <name>Referred to</name>
                </item>
              </activities>
              <name>Crime, Terrorism, Homeland Security, and Investigations Subcommittee</name>
              <systemCode>hsju08</systemCode>
            </item>
          </subcommittees>
          <name>Judiciary Committee</name>
          <systemCode>hsju00</systemCode>
        </item>
        <item>
          <activities>
            <item>
              <date>2013-02-13T15:08:30Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <chamber>House</chamber>
          <type>Standing</type>
          <subcommittees>
            <item>
              <activities>
                <item>
                  <date>2013-02-15T21:16:39Z</date>
                  <name>Referred to</name>
                </item>
              </activities>
              <name>Health Subcommittee</name>
              <systemCode>hsif14</systemCode>
            </item>
          </subcommittees>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </item>
      </billCommittees>
    </committees>
    <introducedDate>2013-02-13</introducedDate>
    <recordedVotes />
    <titles>
      <item>
        <chamberName />
        <titleType>Short Titles as Introduced</titleType>
        <title>Prescription Drug Abuse Prevention and Treatment Act of 2013</title>
        <chamberCode />
        <parentTitleType />
      </item>
      <item>
        <chamberName />
        <titleType>Official Title as Introduced</titleType>
        <title>To provide for increased Federal oversight of prescription opioid treatment and assistance to States in reducing opioid abuse, diversion, and deaths.</title>
        <chamberCode />
        <parentTitleType />
      </item>
      <item>
        <chamberName />
        <titleType>Display Title</titleType>
        <title>Prescription Drug Abuse Prevention and Treatment Act of 2013</title>
        <chamberCode />
        <parentTitleType />
      </item>
    </titles>
    <sponsors>
      <item>
        <bioguideId>R000011</bioguideId>
        <fullName>Rep. Rahall, Nick J., II [D-WV-3]</fullName>
        <byRequestType />
        <lastName>RAHALL</lastName>
        <firstName>NICK</firstName>
        <middleName>J.</middleName>
        <identifiers>
          <lisID>940</lisID>
          <gpoId>8224</gpoId>
          <bioguideId>R000011</bioguideId>
        </identifiers>
      </item>
    </sponsors>
    <laws />
    <originChamber>House</originChamber>
    <createDate>2013-02-14T07:00:52Z</createDate>
    <notes />
    <title>Prescription Drug Abuse Prevention and Treatment Act of 2013</title>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <billNumber>672</billNumber>
    <committeeReports />
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Administrative law and regulatory procedures</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Drug, alcohol, tobacco use</name>
          </item>
          <item>
            <name>Executive agency funding and structure</name>
          </item>
          <item>
            <name>Health care quality</name>
          </item>
          <item>
            <name>Health facilities and institutions</name>
          </item>
          <item>
            <name>Health information and medical records</name>
          </item>
          <item>
            <name>Health personnel</name>
          </item>
          <item>
            <name>Health programs administration and funding</name>
          </item>
          <item>
            <name>Health promotion and preventive care</name>
          </item>
          <item>
            <name>Performance measurement</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <relatedBills>
      <item>
        <number>348</number>
        <type>S</type>
        <congress>113</congress>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <latestAction>
          <actionDate>2013-02-14</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <latestTitle>Prescription Drug Abuse Prevention and Treatment Act of 2013</latestTitle>
      </item>
    </relatedBills>
    <updateDate>2016-10-25T15:59:06Z</updateDate>
    <amendments />
    <actions>
      <actionTypeCounts>
        <billReferralsAggregate>1</billReferralsAggregate>
        <placeholderTextForH>2</placeholderTextForH>
        <introducedInTheHouse>1</introducedInTheHouse>
        <billReferrals>2</billReferrals>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <item>
        <actionDate>2013-04-08</actionDate>
        <committee>
          <name>Crime, Terrorism, Homeland Security, and Investigations Subcommittee</name>
          <systemCode>hsju08</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2013-02-15</actionDate>
        <committee>
          <name>Health Subcommittee</name>
          <systemCode>hsif14</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <committee>
          <name>Judiciary Committee</name>
          <systemCode>hsju00</systemCode>
        </committee>
        <actionCode>H11100</actionCode>
        <type>IntroReferral</type>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <links />
        <text>Referred to House Judiciary</text>
        <actionDate>2013-02-13</actionDate>
      </item>
      <item>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
        <actionCode>H11100</actionCode>
        <type>IntroReferral</type>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <links />
        <text>Referred to House Energy and Commerce</text>
        <actionDate>2013-02-13</actionDate>
      </item>
      <item>
        <committee />
        <actionCode>H11100-A</actionCode>
        <type>IntroReferral</type>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <links />
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <actionDate>2013-02-13</actionDate>
      </item>
      <item>
        <committee />
        <actionCode>Intro-H</actionCode>
        <type>IntroReferral</type>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <links />
        <text>Introduced in House</text>
        <actionDate>2013-02-13</actionDate>
      </item>
      <item>
        <committee />
        <actionCode>1000</actionCode>
        <type>IntroReferral</type>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <links />
        <text>Introduced in House</text>
        <actionDate>2013-02-13</actionDate>
      </item>
      <actionByCounts>
        <houseOfRepresentatives>7</houseOfRepresentatives>
      </actionByCounts>
    </actions>
    <cosponsors />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

